CHRONIC LEUKEMIAS Flashcards
(105 cards)
-Increased MATURE rather than immature cells in the lymphoid or myeloid lines
-The basic defect in growth control presumably affects [precursor/progenitor] cells, but in these disorders most ________ cells differentiate
-Progression is [slower/faster]; can be [weeks or months] up to years
CHRONIC LEUKEMIAS
progenitor
neoplastic cells
slower
months
2 TYPES OF CHRONIC LEUKEMIAS
- MYELOPROLIFERATIVE NEOPLASMS [MPN]
- LYMPHOPROLIFERATIVE DISORDERS/ MATURE LYMPHOID NEOPLASMS.
-are clonal hematopoietic disorders caused by
genetic mutations in the hematopoietic stem cells (HSCs) that result in expansion, excessive production, and accumulation of mature erythrocytes, granulocytes, platelets, and mast cells
MYELOPROLIFERATIVE NEOPLASMS
MYELOPROLIFERATIVE NEOPLASMS
Each has a chronic course that may terminate as ________ ________, ____________, or a ___________.
Acute leukemia
Myelofibrosis
Coagulopathy
MYELOPROLIFERATIVE NEOPLASMS
Mutation in_________; this discovery allowed for refinement of the classification of MPNs.
Myeloproliferation largely is due to [hyposensitivity or hypersensitivity] or [dependence or independence] of normal cytokine regulation resulting from genetic mutations that reduces ______ levels through _______ _________ systems normally induced by mature cells
JAK2/Janus Kinase 2 [JAK2V617F mutation]
hypersensitivity
independence
cytokine
negative feedback
it is a [pluripotent/multipotent] HSC ______where all of the MPNs involve dysregulation
multipotent hematopoietic stem cell (CD34)
WHO CLASSIFICATION OF MPNs
● ________ MUTATION
-CHRONIC MYELOID LEUKEMIA (CML)
● ________ MUTATION
-POLYCYTHEMIA VERA (PV)
-ESSENTIAL (PRIMARY) THROMBOCYTHEMIA (ET)
-PRIMARY MYELOFIBROSIS (PMF)
BCR-ABL1
JAK2V617F
is an MPN arising from a [single/multiple] genetic translocation in a pluripotential HSC producing a clonal overproduction of the myeloid cell line, specifically __________.
-occurs at _____ ages but is seen predominantly in those aged 46 to 53 years.
CHRONIC MYELOID LEUKEMIA
single
Granulocytes
all ages
it represents about 20% of all cases of leukemia, is slightly more common in men than in women
CHRONIC MYELOID LEUKEMIA
CML begins with a chronic clinical phase and, if untreated, progresses to an accelerated phase in ___ to ____ years and often terminates as _____ leukemia (_____ crisis phase).
3-4
acute, blast
CML
CYTOGENETIC ABNORMALITY:
-Presence of the _______ gene (_________/_____)
-Reciprocal translocation between the [short-p/long-q] of chromosomes___and _____ t(__;__)
-This acquired somatic mutation specifically reflects the translocation of an _____ proto-oncogene from band _____ of chromosome ____ to the ___________ of band q11 of chromosome ____ (___;q11)
-The _______ protein has constitutive kinase activity that deregulates _____ transduction pathways, causing abnormal cell ______, inhibition of _______, and increased proliferation of cells
-Also found in FAB ___ (3-5%) and FAB ___ and ____(10-25%)
BCR-ABL1
Philadelphia Chromosome/Ph’
long, q arms
9 and 22, t[9;22]
ABR- q34 -9
Breakpoint Cluster Region [BCR]- q11-22
[q34;q11]
BCR-ABL: signal, cycling, apoptosis
M1, L1, L2
_______
Most cases (____%) are diagnosed in this phase -Frequent ______, ______ secondary to massive massive pathologic accumulation of myeloid progenitor cells in bone marrow, peripheral blood, and extramedullary tissues
-_________ WITH ALL MATURATIONAL STAGES PRESENT, _________, __________
-Progressive fatigue and malaise, low-grade fever, anorexia, weight loss, and bone pain
-Night _______ and _____, associated with an increased metabolism caused by granulocytic cell turnover
-EM: ______; _______ infarction is common because of the abnormal overproduction and accumulation of granulocyte precursors in the bone marrow, _____, and blood
-On fresh incision, extramyeloid masses appear [color] (_______), presumably because of the presence of the myeloid enzyme _________.
CML
85%
Infection, anemia
Neutrophilia, Basophilia, Eosinophilia
sweat, fever
Splenomegaly, splenic, spleen
green [Chloromas]
myeloperoxidase
________
ACCELERATED PHASE:
-[Increased/Decreased] splenomegaly
-Worsening ______ and _______.
-Gradual failure of response to treatment
-[+/=] cytogenetic abnormalities
-___-___% blasts
______ CRISIS (______):
-involves the peripheral blood, bone marrow, and extramedullary tissues
-Based on AL definitions, blasts constitute more than ___% of total BM cellularity, and the peripheral blood exhibits increased [matured cells or blasts]
-Clinical symptoms of blast crisis mimic those of AL, including severe anemia, leukopenia of all WBCs except _____, and __________.
CML
Increased
anemia, thrombocytopenia
+
10-19% blasts
Blast Crisis [Acute]
20%
blasts
blasts, thrombocytopenia
-referred to as a latter of extramedullary growth may occur as lymphocytic or myeloid cell proliferations.
Granulocytic sarcoma
CML
LABORATORY FINDINGS:
BLOOD:
-Marked expansion of the ________ pool
-Anemia and thrombocytopenia (variable)
-[left/right] shift with few blasts in the peripheral blood
-Extramedullary hematopoiesis (_____, _____)
OTHER LABORATORY FINDINGS:
-_________ and _________ (from cell turnover)
-Detection of t(9;22) translocation (cytogenetic analysis, _______,________)
-[DECREASED/INCREASED] ____ SCORE (is used to differentiate CML from leukemoid reaction)
granulocytic pool
left shift
spleen, liver
Hyperuricemia, uricosuria
FISH, RT-PCR
DECREASED, LAP
CML
LABORATORY FINDINGS:
BONE MARROW:
-Intense [hypocellularity/hypercellularity]
-_______ fibers are increased in approximately 20% of patients
-Increased _________ density is associated with an increase in myelofibrosis
-Presence of _____________ cells
hypercellularity
Reticulin
megakaryocyte
Pseudo-Gaucher cells
__________
-Is a clonal stem cell proliferation affecting primarily the _______ series, characterized by excessive proliferation of it and also usually granulocytic and megakaryocytic elements in the marrow
-The very slow evolution of the malignant erythroid clone leads to overexpansion of the [red/white] cell mass, [hypovolemia/hypervolemia], and splenomegalic red cell pooling
-These consequences eventually cause generalized _______ _______ with subsequent increases in the quantity of all three cell lines.
Polycythemia Vera
erythroid
red
hypervolemia
marrow hyperplasia
PV
Associated with the _____ mutation; is detected in more than 95% of patients with PV and is found on chromosome band __p___ ; also associated with ______________[another type]
-__________ phosphorylates signal transducers and activators of transcription______ proteins, eventually generating transcription proteins that bind promotor regions and signal gene expression
-Controls transphosphorylation through conformational _________.
-Constitutive ______ _______ activity of the mutated causes [continous/non-continuous] activation of several signal transduction pathways— that are normally activated after erythropoietin stimulation via the erythropoietic receptor.
-Mutated is active and will phosphorylate ____ proteins in the absence of ________ or will overphosphorylate in its presence
JAK2V617F
9p24
JAK2 exon 12 mutation
JAK2 protein– Tyrosine kinase
STAT
inhibition
tyrosine kinase
continous
STAT
EPO
________ POLYCYTHEMIA VERA
>Increased Hct: increase BM production
>Types: Primary, secondary with appropriate EPO production, inappropriate production of EPO
> PRIMARY
-_________
-Increased BM production of erythrocytes, leukocytes, and thrombocytes
-EPO: [increased/decreased]
> SECONDARY WITH APPOPRIATE EPO PRODUCTION
-Occurs in response to ______
-Patients with _______disease
-Increased BM production of erythrocytes, leukocytes, and thrombocytes
-EPO: [increased/decreased]
> SECONDARY WITH INAPPROPRIATE EPO PRODUCTION
-_____ of kidneys, liver, brain, adrenals
-Increased erythrocytes, leukocytes, and thrombocytes
-EPO: [increased/decreased]
ABSOLUTE
Panmyelosis
Decreased
hypoxia
cardiac/pulmonary
Increased
Tumors
Increased
> RELATIVE POLYCYTHEMIA VERA
Increase ______; Decrease ______ volume
Dehydration, stress, spurious polycythemia, anxiety
_________ ________: spurious polycythemia
Hct, Plasma
Gaisbock’s syndrome
CLINICAL FINDINGS:
>PV often presents with a history of [mild/severe] symptoms occurring for several [months/years]
- Increased RCM produces blood [hypoviscosity/hyperviscosity] , often resulting in __________ disease
- In the early stages of the disease, before treatment, extended periods of high HCT (60%) and hyperviscosity produce ________ in about 50% of patients with PV
- Hyperviscosity and hyperproliferation and include headache, weakness, [a skin condition], weight loss, and fatigue
- About half of PV patients have ________ and 1/3 experience ______ or ________ episodes
mild
years
hyperviscosity– cardiovascular disease
hypertension
pruritis
thrombocytosis
hemorrhagic and thrombotic episodes
> PV patients older than __ years of age or those associated with a history of thrombosis are considered high risk for thrombotic or hemorrhagic events
> The stable phase of PV can progress to a ____ phase in a few patients, usually within ____ years from diagnosis
- Splenomegaly (palpable spleen)
- Hypersplenism
- BM hyperplasia
- ________ [low RBC, WBC. PLT]
___________: Triad of ________, _________, and _______ with [abnormal RBC morphology] and develops in about 30% of PV patients within 20 years
60
Spent phase
10 years
Cytopenia
Postpolycythemic myeloid metaplasia
myelofibrosis, splenomegaly, anemia
teardrop-shaped poikilocytes
_______________
LABORATORY FINDINDS:
>Common morphologic patterns in peripheral blood and BM _______ and cellular changes
>BM normoblasts may collect in large clusters, __________ are enlarged and exhibit lobulated nuclei, and BM ______ are enlarged without fibrosis
>Pseudo-Gaucher cells are rare
> 80% of patients manifest BM ________.
PV
morphologic
megakaryocytes
sinuses
panmyelosis
_____________:AKA [name three]
-a clonal MPN with increased megakaryopoiesis and thrombocytosis, usually with a count greater than _____ x 109/L ; sometimes with a count greater than ______ x 109/L
-However, WHO criteria require a sustained thrombocytosis with a platelet count of ______ x 109/L –
Associated with mutations in:
_____ (64.1%) ____ (4.3%) ____ (15.5)
ESSENTIAL THROMBOCYTHEMIA
Primary thrombocytosis, Idopathic thrombocytosis, Hemorrhagic thrombocythaemia
600
1000
400
JAK2, MPL, CALR [calreticulin]